Osteoporosis in men

Male osteoporosis is common, with a 1 in 5 lifetime risk of fracture over the age of 50 years. Male osteoporosis is both underdiagnosed and undertreated. Men with fractures have higher mortality than men without fractures, and this is higher than that found in women. Secondary causes are very common in men with osteoporosis. There is now evidence for the use of oral and intravenous bisphosphonates, strontium ranelate, teriparatide, and denosumab to treat male osteoporosis.